Veracyte, Inc.
VCYT
$46.41
$0.140.30%
NASDAQ
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | 8.09% | -1.11% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 8.09% | -1.11% | |||
| Cost of Revenue | 0.52% | -22.38% | |||
| Gross Profit | 10.66% | 9.01% | |||
| SG&A Expenses | 16.75% | 9.35% | |||
| Depreciation & Amortization | -3.77% | -1.29% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 9.38% | 0.35% | |||
| Operating Income | 1.47% | -7.99% | |||
| Income Before Tax | -11.51% | -26.23% | |||
| Income Tax Expenses | -18.47% | 346.02% | |||
| Earnings from Continuing Operations | -11.21% | -30.24% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -11.21% | -30.24% | |||
| EBIT | 1.47% | -7.99% | |||
| EBITDA | -0.92% | -6.13% | |||
| EPS Basic | -11.69% | -30.56% | |||
| Normalized Basic EPS | -11.97% | 6.37% | |||
| EPS Diluted | -11.43% | -29.65% | |||
| Normalized Diluted EPS | -12.33% | 6.96% | |||
| Average Basic Shares Outstanding | 0.55% | 0.45% | |||
| Average Diluted Shares Outstanding | 0.92% | -0.09% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||